Literature DB >> 28215720

Tackling the Next Generation of Resistance in EGFR-Mutant Lung Cancer.

Zofia Piotrowska1, Lecia V Sequist2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28215720     DOI： 10.1016/j.jtho.2017.01.018

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  1 in total

1.  Erlotinib and Trametinib in Patients With EGFR-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor.

Authors:  Jia Luo; Alex Makhnin; Yosef Tobi; Linda Ahn; Sara A Hayes; Afsheen Iqbal; Kenneth Ng; Maria E Arcila; Gregory J Riely; Mark G Kris; Helena A Yu
Journal:  JCO Precis Oncol       Date:  2021-01-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.